- Previous Close
0.6407 - Open
0.6200 - Bid --
- Ask --
- Day's Range
0.6200 - 0.6649 - 52 Week Range
0.4700 - 2.1700 - Volume
73,420 - Avg. Volume
1,056,450 - Market Cap (intraday)
2.5M - Beta (5Y Monthly) 1.27
- PE Ratio (TTM)
-- - EPS (TTM)
-29.4700 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.
investors.aquabounty.comRecent News: AQB
View More
Performance Overview: AQB
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AQB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AQB
View MoreValuation Measures
Market Cap
2.53M
Enterprise Value
5.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.16
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-5.37%
Return on Equity (ttm)
-125.79%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-113.75M
Diluted EPS (ttm)
-29.4700
Balance Sheet and Cash Flow
Total Cash (mrq)
230.36k
Total Debt/Equity (mrq)
20.89%
Levered Free Cash Flow (ttm)
3.28M